Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
New Study Shows GlycoMark® Test Identifies Prediabetic Individuals with the Highest Risk of Developing Diabetes Before Symptoms Develop 2023-02-21 20:30
Organizational-level, Unified and Vendor-neutral Enterprise Imaging and Informatics Drive Effective Digital Transformation 2023-02-21 16:12
Synbio Tech Inc. and Cosmax Group signed an exclusive cooperation agreement to jointly expand the South Korean probiotics market 2023-02-21 16:01
Nippon Express Singapore Receives IATA CEIV Pharma Certification for Changi International Airport Facility 2023-02-21 14:00
Pharming announces first patient enrolled in pediatric clinical trial of leniolisib 2023-02-21 14:00
Chrysalis Advisory and TriNetX Establish a Strategic Collaboration to Support Research Teams Across Australia and New Zealand 2023-02-21 13:00
Ascletis Presented Positive Phase I Clinical Data for Broad-Spectrum Antiviral Double Prodrug ASC10 at CROI 2023 2023-02-21 08:10
iGene Laboratory Announces Launch of Whole Exome Sequencing Service 2023-02-21 08:00
Significant Progress Made on the Trivalent Recombinant Protein COVID-19 Vaccine against Subvariants including XBB.1.5 and BA.5 by WestVac Biopharma 2023-02-20 12:43
Detailed Results from Telix's ZIRCON Phase III Kidney Cancer Imaging Study Presented at ASCO GU 2023-02-20 07:10
Biosyngen has obtained FDA IND clearance of BRG01 for Phase I/II clinical trials against Nasopharyngeal Cancer 2023-02-17 23:13
Farrer Park Hospital launches clinical collaboration with ARC Hospitals 2023-02-17 20:38
/C O R R E C T I O N -- DoctorOnCall/ 2023-02-17 08:00
Dalton Announces Major Expansion in Commercial Sterile Manufacturing Capacity 2023-02-17 01:37
Immuno Cure kick off Phase I Clinical Trial in Shenzhen 2023-02-16 20:36
Oral Presentation at APASL Annual Meeting 2023 Demonstrates ASC22, a Subcutaneous PD-L1 Antibody, Can Achieve Functional Cure of Chronic Hepatitis B 2023-02-16 17:10
Aqilion announces pre-clinical licensing and strategic research collaboration agreement with Merck 2023-02-16 15:00
Pharming provides update on EMA regulatory review of leniolisib for APDS in Europe 2023-02-16 14:00
Boan Biotech's Investigational Long-acting Anti-IL-4Rα Antibody BA2101 Administered for First Patient in Phase I Clinical Trial 2023-02-16 08:15
Innovent Announces First Patient Dosed in a Phase 3 Clinical Trial (CLEAR) of Picankibart (Anti-IL23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Plaque Psoriasis 2023-02-16 08:00
1 132 133 134 135 136 535